Stock data

長聖 (6712)

長聖 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$110.47M, up 21.3% from a year earlier. EPS over the last four quarters totals NT$5.06.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 長聖 in Insightr